drugset / Trial / NCT00682344
Pharmacokinetic of levobupivacaïne After Sciatic Nerve Block in Children
Non-randomizedSingle-groupOpen-label
Summary
Levobupivacaïne (Chirocaine®) is a new local anaesthetic recently marketed in France. The goal of this prospective work is to study the pharmacokinetic aspect of this drug after injection around the sciatic nerve (subgluteal way).
Timeline
- Start
- 2008-01
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levobupivacaine | Other / unclassified | 1.75 mg/kg | Other |
Indications
No indication recorded.